Karuna Pharmaceuticals' Series A Round

Karuna Pharmaceuticals raised a round of funding on August 02, 2018.

Karuna is a clinical-stage drug development company targeting muscarinic receptors for the treatment of psychosis and cognition across central nervous system (CNS) disorders, including schizophrenia a…

Articles about Karuna Pharmaceuticals' Series A Round: